0

Journal Articles

in Hepatobiliary Cancer
 1-20 of 124 Articles
Original Article |  May 08, 2013 ONLINE FIRST
Long-term Outcomes Following Tumor Ablation for Treatment of Bilateral Colorectal Liver Metastases
Paul J. Karanicolas, MD, PhD; William R. Jarnagin, MD; Mithat Gonen, PhD; et al.
JAMA Surg. 2013;():1-4. doi:10.1001/jamasurg.2013.1431.
Invited Critique |  May 08, 2013 ONLINE FIRST
To Ablate or Not to Ablate?: That Is the Question:  Comment on “Tumor Ablation Outcomes Following Tumor Ablation for Treatment of Bilateral Colorectal Liver Metastases”
Karen L. Sherman, MD; David J. Bentrem, MD, MS
JAMA Surg. 2013;():1. doi:10.1001/jamasurg.2013.1447.
Invited Critique |  April 01, 2013
Treatment Sequence for Colorectal Cancer With Hepatic Metastases:  Comment on “The Liver-First Approach to the Management of Colorectal Cancer With Synchronous Hepatic Metastases”
Andrew Klein, MD, MBA
JAMA Surg. 2013;148(4):392. doi:10.1001/jamasurg.2013.1236.
Review Article |  April 01, 2013
The Liver-First Approach to the Management of Colorectal Cancer With Synchronous Hepatic Metastases:  A Systematic Review
Santhalingam Jegatheeswaran, MRCS; James M. Mason, DPhil; Helen C. Hancock, PhD; et al.
JAMA Surg. 2013;148(4):385-391. doi:10.1001/jamasurg.2013.1216.
Special Feature |  February 01, 2013
Image of the Month—Quiz Case
Mariana Chavez, MD; Jennifer Danniel, MD; Ronald Miick, MD; et al.
JAMA Surg. 2013;148(2):203. doi:10.1001/jamasurgery.2013.417a 10.1001/jamasurgery.2013.417b.
Special Feature |  February 01, 2013
Image of the Month—Diagnosis
JAMA Surg. 2013;148(2):204. doi:10.1001/archsurg.148.2.204.
Original Article |  December 01, 2012
Prospective Evaluation of Accuracy of Liver Biopsy Findings in the Identification of Chemotherapy-Associated Liver Injuries
Luca Viganò, MD; Nicoletta Ravarino, MD; Alessandro Ferrero, MD; et al.
Arch Surg. 2012;147(12):1085-1091. doi:10.1001/archsurg.2012.1867.
Original Article |  December 01, 2012
Risk and Cost-effectiveness of Surveillance Followed by Cholecystectomy for Gallbladder Polyps
Vaux Cairns, MBChB; Christopher P. Neal, MD, MRCS; Ashely R. Dennison, MD, FRCS; et al.
Arch Surg. 2012;147(12):1078-1083. doi:10.1001/archsurg.2012.1948.
INCLUDES: CME
Invited Critique |  December 01, 2012
Finding 'em? Following 'em? Fixing 'em?:  Comment on “Risk and Cost-Effectiveness of Surveillance Followed by Cholecystectomy for Gallbladder Polyps”
Jonathan Koea, MD, FRACS
Arch Surg. 2012;147(12):1084. doi:10.1001/archsurg.2012.1959.
Original Article |  December 01, 2012
Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma:  A Multi-institutional Analysis of 434 Patients
Dario Ribero, MD; Antonio Daniele Pinna, MD; Alfredo Guglielmi, MD; et al.
Arch Surg. 2012;147(12):1107-1113. doi:10.1001/archsurg.2012.1962.
INCLUDES: CME
Invited Critique |  November 01, 2012
Another Club in the Bag :  Comment on “Irreversible Electroporation for the Ablation of Liver Tumors”
Steven D. Colquhoun, MD
Arch Surg. 2012;147(11):1061. doi:10.1001/jamasurg.2013.493.
Special Feature |  November 01, 2012
Image of the Month—Quiz Case
Antonio Pio Tortorelli, MD; Sergio Alfieri, MD; Alejandro Martin Sanchez, MD; et al.
Arch Surg. 2012;147(11):1063. doi:10.1001/archsurg.2011.1620a 10.1001/archsurg.2011.1620b.
Review Article |  November 01, 2012
Irreversible Electroporation for the Ablation of Liver Tumors:  Are We There Yet?
Kevin P. Charpentier, MD
Arch Surg. 2012;147(11):1053-1061. doi:10.1001/2013.jamasurg.100.
Invited Critique |  September 01, 2012
When pNETs Bust Out of Their Shells
Bruce E. Stabile, MD
Arch Surg. 2012;147(9):828. doi:10.1001/archsurg.2012.1281.
Special Feature |  September 01, 2012
Image of the Month—Diagnosis
Arch Surg. 2012;147(9):888. doi:10.1001/archsurg.147.9.888.
Paper |  September 01, 2012
Lymph Nodes and Survival in Pancreatic Neuroendocrine Tumors
Geoffrey W. Krampitz, MD; Jeffrey A. Norton, MD; George A. Poultsides, MD; et al.
Arch Surg. 2012;147(9):820-827. doi:10.1001/archsurg.2012.1261.
Original Article |  February 01, 2012 FREE
The Effect of Age on the Long-term Prognosis of Patients With Hepatocellular Carcinoma After Resection Surgery:  A Propensity Score Matching Analysis
Chien-Wei Su, MD; Hao-Jan Lei, MD; Gar-Yang Chau, MD, MPH; et al.
Arch Surg. 2012;147(2):137-144. doi:10.1001/archsurg.2011.288.
INCLUDES: CME , Supplemental Content
Correspondence |  January 01, 2012
The Effect of HLA-DR Matching on Pediatric Kidney TransplantationNeuroendocrine Liver Metastasis: Transplant as Part of Multimodality Liver-Directed Therapy
Vincenzo Grimaldi, BiolD, MS; Claudio Napoli, MD, PhD; Peter G. Stock, MD, PhD; et al.
Arch Surg. 2012;147(1):97-98. doi:.
Original Article |  January 01, 2012 FREE
Improvement in Perioperative and Long-term Outcome After Surgical Treatment of Hilar Cholangiocarcinoma:  Results of an Italian Multicenter Analysis of 440 Patients
Gennaro Nuzzo, MD; Felice Giuliante, MD; Francesco Ardito, MD; et al.
Arch Surg. 2012;147(1):26-34. doi:10.1001/archsurg.2011.771.
Invited Critique |  October 01, 2011
Porcelain Gallbladder and Risk of Gallbladder Cancer :  Comment on “Reassessing the Need for Prophylactic Surgery in Patients With Porcelain Gallbladder”
Kimberly M. Brown, MD; David A. Geller, MD
Arch Surg. 2011;146(10):1148. doi:10.1001/archsurg.2011.258.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Clinical Sciences  |  February 7, 2013
Progression of Ocular Melanoma Metastasis to the Liver:  The 2012 Zimmerman Lecture
Hans E. Grossniklaus, MD
JAMA
Preliminary Communication  |  November 14, 2012
Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
Chun-Ying Wu, MD, PhD, MPH; Yi-Ju Chen, MD, PhD; Hsiu J. Ho, PhD; et al.
JAMA
Editorial  |  November 14, 2012
Does Antiviral Therapy Prevent Recurrence of Hepatitis B Virus–Related Hepatocellular Carcinoma After Curative Liver Resection?
Anna S. F. Lok, MD
JAMA
Preliminary Communication  |  November 17, 2010
Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma:  A Randomized Trial
Ghassan K. Abou-Alfa, MD; Philip Johnson, MD; Jennifer J. Knox, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems